Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-3117false2023-01-01falseNo description of principal activity17falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 04155946 2022-12-31 04155946 2023-01-01 2023-12-31 04155946 2023-12-31 04155946 2021-07-01 2022-06-30 04155946 2022-06-30 04155946 c:CompanySecretary1 2023-01-01 2023-12-31 04155946 c:Director1 2023-01-01 2023-12-31 04155946 c:RegisteredOffice 2023-01-01 2023-12-31 04155946 d:Buildings 2023-01-01 2023-12-31 04155946 d:Buildings 2023-12-31 04155946 d:Buildings 2022-06-30 04155946 d:Buildings d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 04155946 d:Buildings d:LongLeaseholdAssets 2023-01-01 2023-12-31 04155946 d:PlantMachinery 2023-01-01 2023-12-31 04155946 d:OfficeEquipment 2023-01-01 2023-12-31 04155946 d:OtherPropertyPlantEquipment 2023-01-01 2023-12-31 04155946 d:OtherPropertyPlantEquipment 2023-12-31 04155946 d:OtherPropertyPlantEquipment 2022-06-30 04155946 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 04155946 d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 04155946 d:CurrentFinancialInstruments 2023-12-31 04155946 d:CurrentFinancialInstruments 2022-06-30 04155946 d:Non-currentFinancialInstruments 2023-12-31 04155946 d:Non-currentFinancialInstruments 2022-06-30 04155946 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 04155946 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 04155946 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 04155946 d:Non-currentFinancialInstruments d:AfterOneYear 2022-06-30 04155946 d:ShareCapital 2023-12-31 04155946 d:ShareCapital 2022-06-30 04155946 d:RetainedEarningsAccumulatedLosses 2023-12-31 04155946 d:RetainedEarningsAccumulatedLosses 2022-06-30 04155946 c:FRS102 2023-01-01 2023-12-31 04155946 c:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 04155946 c:FullAccounts 2023-01-01 2023-12-31 04155946 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 04155946 2 2023-01-01 2023-12-31 04155946 e:PoundSterling 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure
Company registration number: 04155946







UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 DECEMBER 2023


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED






































img568a.png                        

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
COMPANY INFORMATION


Director
R S Singh 




Company secretary
M J Miles



Registered number
04155946



Registered office
Blays Cottage
Blays Lane

Englefield Green

Egham

Surrey

TW20 0PB




Accountants
Menzies LLP
Chartered Accountants

1st Floor

Midas House

62 Goldsworth Road

Woking

Surrey

GU21 6LQ





 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 



CONTENTS



Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 8


 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
REGISTERED NUMBER:04155946



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
85,571
9,965

  
85,571
9,965

Current assets
  

Stocks
  
723,890
630,392

Debtors: amounts falling due within one year
 5 
1,594,491
2,013,613

Bank and cash balances
  
428,237
808,742

  
2,746,618
3,452,747

Creditors: amounts falling due within one year
 6 
(1,807,516)
(2,349,659)

Net current assets
  
 
 
939,102
 
 
1,103,088

Total assets less current liabilities
  
1,024,673
1,113,053

Creditors: amounts falling due after more than one year
 7 
(226,428)
(466,429)

  

Net assets
  
798,245
646,624

Page 1

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
REGISTERED NUMBER:04155946


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2023

2023
2022
£
£

Capital and reserves
  

Called up share capital 
  
2,300
2,000

Profit and loss account
  
795,945
644,624

  
798,245
646,624


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
R S Singh
Director

Date: 23 August 2024

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

Health-Care Equipment and Supplies Limited is a private company limited by shares incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of its registered office and the principal place of business is disclosed on the company information page.
The Company extended its year end from 30 June 2023 to 31 December 2023 as part of the company restructuring plans. These financial statements present the activity of the company for the 18 month period ended 31 December 2023 which are not entirely comparable to the previous 12 months ended 30 June 2023.
The Company's functional and presentational currency is GBP.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Income and Retained Earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on the following basis:.

Depreciation is provided on the following basis:

Long-term leasehold improvements
-
over 10 years
Plant and machinery
-
18% reducing balance
Office and Computer Equipment
-
18% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a weighted average basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.8

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 5

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

3.


Employees

The average monthly number of employees, including directors, during the period was 17 (2022 -17).


4.


Tangible fixed assets





Leasehold improvement
Plant and machinery et.
Total

£
£
£



Cost or valuation


At 1 January 2023
6,092
89,991
96,083


Additions
-
95,429
95,429



At 31 December 2023

6,092
185,420
191,512



Depreciation


At 1 January 2023
1,218
84,900
86,118


Charge for the period on owned assets
914
18,909
19,823



At 31 December 2023

2,132
103,809
105,941



Net book value



At 31 December 2023
3,960
81,611
85,571



At 31 December 2022
4,874
5,091
9,965

Page 6

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

5.


Debtors

2023
2022
£
£


Trade debtors
650,877
669,041

Amounts owed by group undertakings
-
929,423

Other debtors
911,502
351,713

Prepayments and accrued income
32,112
63,436

1,594,491
2,013,613



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
75,000
75,000

Trade creditors
705,333
1,368,630

Amounts owed to group undertakings
-
374,055

Corporation tax
71,395
82,937

Other taxation and social security
12,869
10,632

Other creditors
867,657
382,591

Accruals and deferred income
75,262
55,814

1,807,516
2,349,659



7.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
112,499
225,000

Other creditors
113,929
241,429

226,428
466,429


The bank loans are secured by way of a fixed and floating charge over the company's assets.


8.


Commitments under operating leases

The Company had total commitments under non-cancellable operating leases of £123,750 (2022 - £92,000) at the reporting date.

Page 7

 


HEALTH-CARE EQUIPMENT AND SUPPLIES CO LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

9.


Transactions with directors


Brought Forward 1.7.2022
Advances/ Credits
Repaid
Carried Forward 31.12.2023
£
£
£
£

Directors loan
169,152
2,982
(169,152)
2,982
169,152
2,982
(169,152)
2,982

 
Page 8